COVID-19 UPDATES

MPOX UPDATES

COVID VACCINE OPEN SCHEDULING

Schedule your COVID vaccine appointment online.


Updated 5/15/23

Latest updates

We are providing COVID-19 primary series vaccines as well as bivalent boosters to all eligible individuals.

Please note: Based on current COVID-19 trends, the nation’s Public Health Emergency (PHE) for COVID-19 ended on May 11, 2023. This resulted in changes to the cost of COVID-19 treatments, tests and vaccines for some individuals. Please check your individual health insurance coverage to understand how these changes apply to you. Learn more about post-PHE changes.

The CDC updated its guidance on April 19, 2023. Learn more here.

  • An additional bivalent dose for adults ages 65 years and older
  • Additional doses for people who are immunocompromised and more flexibility for healthcare providers to administer additional doses to immunocompromised patients as needed
  • Withdrawal of monovalent (original) COVID-19 mRNA COVID-19 vaccines from use in the United States
  • Everyone aged 6 years and older receive a bivalent mRNA COVID-19 vaccine, regardless of whether they previously completed their (monovalent) primary series
  • Individuals aged 6 years and older who have already received an updated mRNA vaccine do not need to take any action unless they are immunocompromised
  • For young children, multiple doses continue to be recommended and vary by age, vaccine, and which vaccine brands were previously received

Alternatives to mRNA COVID-19 vaccines remain available for people who cannot or will not receive an mRNA vaccine. CDC’s recommendations for use of (monovalent) Novavax or Johnson & Johnson’s Janssen COVID-19 vaccines were not affected by the changes made today

COVID-19 Booster Guidance

Eligible ForIf you Received
Pfizer-BioNTech
If you Received
Moderna
If you Received
J&J
Additional Primary Shot
(for those moderate to severely immunocompromised)
People age 5+ who are moderately or severely immunocompromised should get an additional primary shot of Pfizer-BioNTech COVID-19 vaccine

Given 28 days after 2nd shot
People age 18+ who are moderately or severely immunocompromised should get an additional primary shot of Moderna COVID-19 vaccine

Given 28 days after 2nd shot
No additional primary shot is recommended at this time
1st Booster ShotTeens ages 12–17 should only get a Pfizer-BioNTech COVID-19 vaccine booster shot

People age 18+ should get a booster shot of either Pfizer-BioNTech or Moderna (mRNA COVID-19 vaccines) in most situations

Given at least 5 months after completing the primary series
People age 18+ should get a booster shot of either Pfizer-BioNTech or Moderna (mRNA COVID-19 vaccines) in most situations

Given at least 5 months after an additional primary shot
People age 18+ should get a booster shot of either Pfizer-BioNTech or Moderna (mRNA COVID-19 vaccines) in most situations

Given at least 2 months after the initial J&J vaccine.
2nd Booster ShotPeople age 50+ should get a 2nd booster shot of either Pfizer-BioNTech or Moderna (mRNA COVID-19 vaccines) in most situations.

People age 12+ who are moderately or severely immunocompromised should get a 2nd booster shot of only Pfizer-BioNTech in most situations.

Given at least 4 months after 1st booster shot
People age 18-49 who are moderately or severely immunocompromised should get a 2nd booster shot of either Pfizer-BioNTech or Moderna (mRNA COVID-19 vaccines) in most situations

Given at least 4 months after 1st booster shot
People age 50+ should get a 2nd booster shot of either Pfizer-BioNTech or Moderna (mRNA COVID-19 vaccines) in most situations, given at least 4 months after 1st booster shot

People age 18-49 who are moderately or severely immunocompromised should get a 2nd booster shot of either Pfizer-BioNTech or Moderna (mRNA COVID-19 vaccines) in most situations

Given at least 4 months after 1st booster shot

** People ages 18 through 49 years who got a J&J/Janssen COVID-19 vaccine for BOTH their primary dose and 1st booster can choose to get a 2nd booster of either Pfizer-BioNTech or Moderna COVID-19 vaccine at least 4 months after their 1st booster. This booster is not required to be considered up to date

A parent or legal guardian must accompany anyone under 18 years of age.

Updated CDC guidance recommends an additional primary dose (3rd dose) to immunocompromised children aged 5-11 years-old 28 days after their primary vaccination series. It has approved a booster (4th dose) for all patients 12 and up 5 months after their 3rd dose.

Northwest Community Hospital is offering the Pfizer Covid-19 vaccine. Learn more by calling 847-618-0242 to schedule an appointment.

Immunocompromised patients include those who are:

  • In active treatment for solid tumor and hematologic malignancies
  • In receipt of solid-organ transplant and taking immunosuppressive therapy
  • In receipt of CAR-T-cell or hematopoietic stem cell transplant (within 2 years of transplantation or taking immunosuppression therapy)
  • Have moderate or severe primary immunodeficiency (e.g., DiGeorge syndrome, Wiskott-Aldrich syndrome)
  • Advanced or untreated HIV infection
  • In active treatment with high-dose corticosteroids (i.e., ≥20mg prednisone or equivalent per day), alkylating agents, antimetabolites, transplant-related immunosuppressive drugs, cancer chemotherapeutic agents classified as severely immunosuppressive, tumor-necrosis (TNF) blockers and other biologic agents that are immunosuppressive or immunomodulatory.
© 2023 Northwest Community Healthcare. All rights reserved.